title: Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
authors.affiliation: Transplantation Unit, CHU Grenoble, France.
authors.forename: P
authors.initials: P
authors.lastname: Zaoui
authors.forename: F
authors.initials: F
authors.lastname: Serre-Debeauvais
authors.forename: F
authors.initials: F
authors.lastname: Bayle
authors.forename: G
authors.initials: G
authors.lastname: Bessard
authors.forename: P
authors.initials: P
authors.lastname: Pintar
authors.forename: P
authors.initials: P
authors.lastname: Deteix
authors.forename: B
authors.initials: B
authors.lastname: Janbon
authors.forename: P
authors.initials: P
authors.lastname: Vialtel
mesh_terms: D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006207:Half-Life; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D012263:Ribonucleosides / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003404:Creatinine